Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children

NCT ID: NCT02509936

Last Updated: 2019-11-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

324 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to evaluate the impact of an intensive home-based education intervention targeting severely stunted Guatemalan children for catch up growth and improved development. Half of the children in the study will receive standard of care, which includes micronutrient supplementation and a food ration. The other half of children in the study will receive, in addition to the above, home-based dietary assessment and individualized parental nutrition education.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malnutrition Developmental Disabilities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of Care Arm

In this arm enrolled children will receive the national standard of care for growth support, which includes growth monitoring, a food ration, and a multiple micronutrient powder supplement.

Group Type ACTIVE_COMPARATOR

Standard-of-care nutrition support

Intervention Type DIETARY_SUPPLEMENT

Subjects will be provided with a standard food ration and with a multiple micronutrient powder dietary supplement (Chispitas)

Home-based Education

In the intervention arm, children will receive the national standard of care for growth support, which includes growth monitoring, a food ration, and a multiple micronutrient powder supplement. In addition, they will receive monthly home visits from a community health promoter who will provide detailed dietary assessments and individualized dietary coaching and education to parents.

Group Type EXPERIMENTAL

Home-based nutrition education

Intervention Type BEHAVIORAL

Health promoters will use 24-hour dietary recall information to assess meal frequency and dietary diversity and then provide tailored nutrition coaching to parents.

Standard-of-care nutrition support

Intervention Type DIETARY_SUPPLEMENT

Subjects will be provided with a standard food ration and with a multiple micronutrient powder dietary supplement (Chispitas)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home-based nutrition education

Health promoters will use 24-hour dietary recall information to assess meal frequency and dietary diversity and then provide tailored nutrition coaching to parents.

Intervention Type BEHAVIORAL

Standard-of-care nutrition support

Subjects will be provided with a standard food ration and with a multiple micronutrient powder dietary supplement (Chispitas)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Child aged 6-24 months at time of enrollment
* Height/length for age Z score of less than -2.5
* Child lives with parent/legal guardian

Exclusion Criteria

* Presence of acute malnutrition (weight for length/height Z score of less than -2)
* Presence of other severe medical illness (e.g. congenital heart disease, genetic abnormality)
Minimum Eligible Age

6 Months

Maximum Eligible Age

24 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad del Valle, Guatemala

OTHER

Sponsor Role collaborator

Grand Challenges Canada

OTHER

Sponsor Role collaborator

Wuqu' Kawoq, Maya Health Alliance

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Rohloff, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Wuqu' Kawoq

Maria Grazioso, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad del Valle, Guatemala

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wuqu' Kawoq

Tecpán Guatemala, Departamento de Chimaltenango, Guatemala

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Guatemala

References

Explore related publications, articles, or registry entries linked to this study.

Martinez B, Cardona S, Rodas P, Lubina M, Gonzalez A, Farley Webb M, Grazioso MDP, Rohloff P. Developmental outcomes of an individualised complementary feeding intervention for stunted children: a substudy from a larger randomised controlled trial in Guatemala. BMJ Paediatr Open. 2018 Oct 3;2(1):e000314. doi: 10.1136/bmjpo-2018-000314. eCollection 2018.

Reference Type DERIVED
PMID: 30306144 (View on PubMed)

Martinez B, Webb MF, Gonzalez A, Douglas K, Grazioso MDP, Rohloff P. Complementary feeding intervention on stunted Guatemalan children: a randomised controlled trial. BMJ Paediatr Open. 2018 Apr 27;2(1):e000213. doi: 10.1136/bmjpo-2017-000213. eCollection 2018.

Reference Type DERIVED
PMID: 29719876 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WK-2015-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.